Lourdes Cruz Garin Isarraras, NP
Nurse Practitioner · Sunnyvale
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · California Post-Acute Medical Group 1 Inc · 4 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Lourdes Cruz Garin Isarraras’s office at (408) 739-2383 to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$135,371
Medicare paid this office $135,371 for 111 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 90 | $111,519 | $82 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 42 | $9,304 | $115 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 35 | $7,071 | $54 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 26 | $4,389 | $169 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day at least 10 minutes | 16 | $1,177 | $30 |
See all 6 services
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 90 | $111,519 | $82 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 42 | $9,304 | $115 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 35 | $7,071 | $54 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 26 | $4,389 | $169 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day at least 10 minutes | 16 | $1,177 | $30 |
| Residence visit for established patient with low level of medical decision making, per day at least 30 minutes | 12 | $442 | $25 |
Who their Medicare patients are
111 Original Medicare patients in 2024. Average age 76 · Under 65 12% · 85 and older 24% · Women 60% · Also on Medicaid 80% · Health risk score 2.19. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Dementia 50% · Depression 45% · Diabetes 42% · Chronic kidney disease 41% · COPD 32% · Atrial fibrillation 30% · Heart failure 29% · Coronary heart disease 24% · Stroke 24% · Cancer 13%.
The office billed $566,732, Medicare allowed $176,772 and paid $135,371; for 1,684 services of 11 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 111 | 1,684 | 76 | 2.19 | $566,732 | $135,371 |
| 2023 | 131 | 1,630 | 78 | 2.08 | $541,032 | $127,259 |
| 2022 | 128 | 1,420 | 77 | 2.22 | $460,523 | $95,513 |
| 2021 | 126 | 1,581 | 77 | 2.12 | $452,394 | $112,908 |
| 2020 | 123 | 1,377 | 75 | 2.50 | $369,755 | $91,927 |
| 2019 | 123 | 1,305 | 74 | 2.48 | $342,230 | $91,648 |
| 2018 | 152 | 1,419 | 72 | 2.64 | $360,031 | $101,966 |
| 2017 | 80 | 458 | 72 | 2.90 | $110,776 | $32,609 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 90 | $97,220 | $81 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 43 | $6,859 | $52 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 36 | $6,853 | $120 |
| Residence visit for established patient with moderate level of medical decision making, per day at least 40 minutes | 23 | $5,235 | $97 |
| Residence visit for established patient with low level of medical decision making, per day at least 30 minutes | 31 | $3,485 | $51 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day at least 10 minutes | 17 | $1,129 | $29 |
2022: 7 services
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 85 | $70,846 | $67 |
| Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes | 28 | $5,955 | $72 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 38 | $5,851 | $50 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 29 | $5,674 | $105 |
| Nursing facility annual assessment, typically 30 minutes | 29 | $1,991 | $69 |
| Established patient custodial care facility, group care, or assisted living visit, typically 40 minutes | 11 | $1,155 | $89 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day at least 10 minutes | 13 | $617 | $31 |
2021: 6 services
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 87 | $88,091 | $73 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 44 | $7,071 | $53 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 37 | $5,826 | $108 |
| Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes | 34 | $5,631 | $72 |
| Nursing facility annual assessment, typically 30 minutes | 29 | $2,273 | $78 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day at least 10 minutes | 14 | $636 | $26 |
2020: 6 services
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 96 | $71,852 | $68 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 57 | $8,298 | $54 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 28 | $4,208 | $105 |
| Nursing facility annual assessment, typically 30 minutes | 44 | $3,157 | $72 |
| Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes | 20 | $2,447 | $66 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day at least 10 minutes | 18 | $964 | $34 |
2019: 5 services
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 96 | $73,098 | $70 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 39 | $4,812 | $53 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 24 | $3,367 | $105 |
| Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes | 18 | $3,252 | $71 |
| Nursing facility annual assessment, typically 30 minutes | 25 | $1,779 | $71 |
2018: 7 services
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 111 | $80,571 | $70 |
| Established patient custodial care facility, group care, or assisted living visit, typically 40 minutes | 24 | $6,791 | $103 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 25 | $4,773 | $106 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 42 | $3,419 | $54 |
| Nursing facility annual assessment, typically 30 minutes | 23 | $1,568 | $68 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day at least 10 minutes | 20 | $801 | $35 |
| Short return visit (20+ min) | 17 | $666 | $39 |
2017: 4 services
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 66 | $25,447 | $71 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 12 | $2,424 | $71 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 24 | $1,992 | $54 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 17 | $1,900 | $106 |
Medicaid work
$5,785 in 2024
Medicaid paid $5,785 for 1,002 billed services this clinician did in 2024, up to 63 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ NURSING FACILITY CARE MOD MDM 30 MINUTES | 1,002 | $5,785 |
| 2024 | 1,002 | 1 | 63 | $5,785 |
| 2023 | 981 | 1 | 36 | $3,484 |
| 2022 | 687 | 3 | 43 | $1,387 |
| 2021 | 735 | 1 | 23 | $2,080 |
| 2020 | 777 | 2 | 62 | $1,184 |
| 2019 | 631 | 1 | 45 | $1,369 |
| 2018 | 512 | 1 | 35 | $606 |
See the largest Medicaid services in earlier years
2023
| SBSQ NURSING FACILITY CARE MOD MDM 30 MINUTES | 981 | $3,484 |
2022
| SBSQ NURSING FACILITY CARE MOD MDM 30 MINUTES | 661 | $1,387 |
| Falls plan of care documented (GER) | 13 | $0 |
| Advance Care Planning discussed and documented advance care plan or surrogate decision maker documented in the medical record (DEM) (GER, Pall Cr) | 13 | $0 |
2021
| SBSQ NURSING FACILITY CARE MOD MDM 30 MINUTES | 735 | $2,080 |
2020
| SBSQ NURSING FACILITY CARE MOD MDM 30 MINUTES | 744 | $1,157 |
| SBSQ NURSING FACILITY CARE LOW MDM 20 MINUTES | 33 | $28 |
2019
| SBSQ NURSING FACILITY CARE MOD MDM 30 MINUTES | 631 | $1,369 |
2018
| SBSQ NURSING FACILITY CARE MOD MDM 30 MINUTES | 512 | $606 |
Drugs they prescribed that Part D paid
$579,076
Pharmacies billed $579,076 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (31 of 3,859) in 2024. Above the middle of the specialty; the typical nurse practitioner clinician is at 0%. Long-acting opioids: 36% of their opioid prescriptions.
2,808 generic and 1,036 brand-name prescriptions · $579,076 in drug cost · 129 antibiotic prescriptions to 37 people · 177 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 267 | $83,232 | $312 |
| Invega Sustenna | 17 | $46,889 | $2,758 |
| Xifaxan | 12 | $41,502 | $3,458 |
| Jardiance | 115 | $35,505 | $309 |
| Fycompa | 26 | $11,782 | $453 |
See all 89 drugs
| Eliquis | 267 | $83,232 | $312 |
| Invega Sustenna | 17 | $46,889 | $2,758 |
| Xifaxan | 12 | $41,502 | $3,458 |
| Jardiance | 115 | $35,505 | $309 |
| Fycompa | 26 | $11,782 | $453 |
| Lagevrio (Eua) | 13 | $11,596 | $892 |
| Risperidone | 51 | $9,629 | $189 |
| Lacosamide | 35 | $7,299 | $209 |
| Brinzolamide | 21 | $6,626 | $316 |
| Xarelto | 21 | $5,964 | $284 |
| Santyl | 16 | $5,680 | $355 |
| Potassium Chloride | 40 | $5,367 | $134 |
| Atorvastatin | 248 | $5,048 | $20 |
| Levothyroxine | 202 | $4,284 | $21 |
| Calcipotriene | 13 | $3,962 | $305 |
| Tamsulosin | 101 | $2,806 | $28 |
| Levetiracetam | 38 | $2,165 | $57 |
| Quetiapine | 48 | $2,130 | $44 |
| Metoprolol | 65 | $2,103 | $32 |
| Nystatin | 68 | $2,097 | $31 |
| Latanoprost | 75 | $1,952 | $26 |
| Metoprolol | 92 | $1,831 | $20 |
| Metformin | 101 | $1,787 | $18 |
| Semglee (Yfgn) | 17 | $1,607 | $95 |
| Ezetimibe | 18 | $1,596 | $89 |
| Finasteride | 41 | $1,437 | $35 |
| Alendronate | 61 | $1,406 | $23 |
| Ipratropium-Albuterol | 44 | $1,391 | $32 |
| Olanzapine | 37 | $1,371 | $37 |
| Clobetasol Propionate | 13 | $1,304 | $100 |
| Basaglar Kwikpen U-100 | 18 | $1,284 | $71 |
| Amlodipine Besylate | 76 | $1,190 | $16 |
| Carbamazepine | 22 | $1,163 | $53 |
| Insulin Lispro Kwikpen U-100 | 28 | $1,106 | $40 |
| Lactulose | 48 | $1,066 | $22 |
| Valproic Acid | 27 | $1,061 | $39 |
| Escitalopram | 29 | $1,050 | $36 |
| Gabapentin | 53 | $881 | $17 |
| Potassium Citrate Er | 14 | $881 | $63 |
| Digoxin | 28 | $878 | $31 |
| Clobazam | 12 | $828 | $69 |
| Pantoprazole | 46 | $827 | $18 |
| Aripiprazole | 28 | $814 | $29 |
| Albuterol Sulfate Hfa | 14 | $756 | $54 |
| Lisinopril | 40 | $733 | $18 |
| Losartan | 40 | $723 | $18 |
| Ssd | 25 | $719 | $29 |
| Famotidine | 45 | $700 | $16 |
| Divalproex | 11 | $699 | $64 |
| Humulin N Kwikpen | 20 | $658 | $33 |
| Lamotrigine | 23 | $631 | $27 |
| Triamcinolone Acetonide | 50 | $630 | $13 |
| Amiodarone | 31 | $610 | $20 |
| Pentoxifylline | 12 | $562 | $47 |
| Chlorhexidine Gluconate | 35 | $554 | $16 |
| Propranolol | 19 | $546 | $29 |
| Fluticasone Propionate | 18 | $544 | $30 |
| Amantadine | 17 | $532 | $31 |
| Rosuvastatin | 11 | $525 | $48 |
| Phenytoin | 11 | $505 | $46 |
| Sertraline | 26 | $497 | $19 |
| Donepezil | 27 | $491 | $18 |
| Furosemide | 47 | $482 | $10 |
| Omeprazole | 28 | $466 | $17 |
| Lantus Solostar | 18 | $453 | $25 |
| Clopidogrel | 14 | $441 | $32 |
| Haloperidol | 15 | $424 | $28 |
| Lithium Carbonate | 42 | $386 | $9 |
| Clonazepam | 19 | $374 | $20 |
| Ketoconazole | 13 | $360 | $28 |
| Allopurinol | 16 | $290 | $18 |
| Silver Sulfadiazine | 15 | $289 | $19 |
| Pravastatin | 13 | $288 | $22 |
| Doxycycline Hyclate | 14 | $273 | $19 |
| Lorazepam | 11 | $267 | $24 |
| Duloxetine | 12 | $242 | $20 |
| Fluoxetine | 12 | $233 | $19 |
| Chlorthalidone | 11 | $229 | $21 |
| Morphine Sulfate Er | 11 | $216 | $20 |
| Atenolol | 19 | $209 | $11 |
| Hydrocodone-Acetaminophen | 13 | $197 | $15 |
| Trazodone | 11 | $190 | $17 |
| Spironolactone | 14 | $182 | $13 |
| Clonidine | 12 | $176 | $15 |
| Amoxicillin-Clavulanate Potass | 22 | $162 | $7 |
| Cephalexin | 18 | $129 | $7 |
| Amoxicillin | 20 | $120 | $6 |
| Hydrochlorothiazide | 12 | $94 | $8 |
| Prednisone | 16 | $90 | $6 |
Year by year
| 2024 | 3,859 | 121 | 1% (31) | 27% | $579,076 |
| 2023 | 2,767 | 121 | 1% (15) | 23% | $311,092 |
| 2022 | 2,353 | 125 | 1% (34) | 25% | $218,309 |
| 2021 | 2,288 | 115 | 2% (44) | 28% | $216,736 |
| 2020 | 2,101 | 106 | 3% (53) | None | $206,394 |
| 2019 | 1,140 | 90 | 3% (38) | None | $92,207 |
| 2018 | 823 | 76 | 12% (97) | 23% | $73,658 |
| 2017 | 37 | 14 | None | None | $1,423 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 67 drugs
| Eliquis | 129 | $44,413 | $344 |
| Lacosamide | 16 | $19,003 | $1,188 |
| Xarelto | 29 | $11,449 | $395 |
| Jardiance | 33 | $9,853 | $299 |
| Breo Ellipta | 22 | $6,546 | $298 |
| Levetiracetam | 55 | $5,658 | $103 |
| Incruse Ellipta | 13 | $4,941 | $380 |
| Gvoke Hypopen 1-Pack | 14 | $4,917 | $351 |
| Santyl | 15 | $4,618 | $308 |
| Levothyroxine | 213 | $4,049 | $19 |
| Atorvastatin | 201 | $3,984 | $20 |
| Combigan | 11 | $3,266 | $297 |
| Divalproex | 15 | $3,201 | $213 |
| Ezetimibe | 17 | $2,861 | $168 |
| Basaglar Kwikpen U-100 | 38 | $2,733 | $72 |
| Humalog | 13 | $2,706 | $208 |
| Latanoprost | 74 | $2,618 | $35 |
| Olanzapine | 17 | $2,565 | $151 |
| Pantoprazole | 90 | $2,253 | $25 |
| Novolin R | 12 | $1,830 | $152 |
| Potassium Chloride | 11 | $1,786 | $162 |
| Risperidone | 33 | $1,732 | $52 |
| Valproic Acid | 17 | $1,730 | $102 |
| Levemir Flexpen | 15 | $1,509 | $101 |
| Nystatin | 46 | $1,501 | $33 |
| Potassium Citrate Er | 18 | $1,312 | $73 |
| Tamsulosin | 46 | $1,275 | $28 |
| Ipratropium-Albuterol | 30 | $1,261 | $42 |
| Gabapentin | 45 | $1,082 | $24 |
| Midodrine | 21 | $987 | $47 |
| Sertraline | 36 | $872 | $24 |
| Escitalopram | 20 | $870 | $44 |
| Alendronate | 48 | $798 | $17 |
| Quetiapine | 19 | $797 | $42 |
| Omeprazole | 41 | $745 | $18 |
| Valproic Acid | 14 | $721 | $52 |
| Metoprolol | 34 | $718 | $21 |
| Mirtazapine | 14 | $711 | $51 |
| Rosuvastatin | 11 | $690 | $63 |
| Ketoconazole | 13 | $662 | $51 |
| Amlodipine Besylate | 49 | $658 | $13 |
| Lamotrigine | 22 | $643 | $29 |
| Metformin | 73 | $601 | $8 |
| Ssd | 18 | $534 | $30 |
| Diclofenac | 16 | $509 | $32 |
| Aripiprazole | 16 | $500 | $31 |
| Digoxin | 16 | $486 | $30 |
| Fluticasone Propionate | 14 | $441 | $31 |
| Clopidogrel | 16 | $440 | $28 |
| Metoprolol | 30 | $440 | $15 |
| Losartan | 28 | $393 | $14 |
| Atenolol | 23 | $392 | $17 |
| Triamcinolone Acetonide | 26 | $352 | $14 |
| Fluoxetine | 18 | $339 | $19 |
| Hydrocodone-Acetaminophen | 12 | $325 | $27 |
| Famotidine | 40 | $315 | $8 |
| Metformin Hcl Er | 22 | $312 | $14 |
| Donepezil | 21 | $303 | $14 |
| Chlorhexidine Gluconate | 28 | $301 | $11 |
| Simvastatin | 12 | $274 | $23 |
| Lithium Carbonate | 25 | $259 | $10 |
| Finasteride | 15 | $257 | $17 |
| Lisinopril | 31 | $242 | $8 |
| Clonazepam | 18 | $173 | $10 |
| Brimonidine | 12 | $159 | $13 |
| Furosemide | 24 | $116 | $5 |
| Lorazepam | 12 | $109 | $9 |
2022: 69 drugs
| Vimpat | 34 | $27,095 | $797 |
| Eliquis | 92 | $26,342 | $286 |
| Xarelto | 40 | $13,771 | $344 |
| Spiriva Handihaler | 23 | $12,236 | $532 |
| Breo Ellipta | 38 | $11,189 | $294 |
| Lantus | 27 | $8,210 | $304 |
| Potassium Chloride | 33 | $6,428 | $195 |
| Budesonide | 11 | $6,031 | $548 |
| Novolog | 18 | $5,676 | $315 |
| Januvia | 19 | $5,041 | $265 |
| Divalproex | 22 | $4,538 | $206 |
| Incruse Ellipta | 18 | $4,511 | $251 |
| Novolin R | 29 | $4,405 | $152 |
| Gvoke Hypopen 1-Pack | 11 | $4,161 | $378 |
| Santyl | 12 | $4,138 | $345 |
| Atorvastatin | 192 | $3,513 | $18 |
| Levetiracetam | 34 | $3,195 | $94 |
| Levothyroxine | 156 | $2,626 | $17 |
| Humalog | 12 | $1,934 | $161 |
| Alendronate | 59 | $1,691 | $29 |
| Latanoprost | 42 | $1,575 | $38 |
| Midodrine | 18 | $1,238 | $69 |
| Ipratropium-Albuterol | 29 | $1,200 | $41 |
| Humulin R | 12 | $1,168 | $97 |
| Pantoprazole | 50 | $950 | $19 |
| Ketoconazole | 16 | $862 | $54 |
| Escitalopram | 17 | $853 | $50 |
| Nystatin | 30 | $813 | $27 |
| Metoprolol | 29 | $768 | $26 |
| Valproic Acid | 12 | $761 | $63 |
| Gabapentin | 51 | $729 | $14 |
| Aripiprazole | 25 | $711 | $28 |
| Tamsulosin | 34 | $694 | $20 |
| Olanzapine | 17 | $682 | $40 |
| Digoxin | 15 | $680 | $45 |
| Memantine | 13 | $675 | $52 |
| Phenytoin | 21 | $638 | $30 |
| Omeprazole | 28 | $621 | $22 |
| Dorzolamide | 14 | $608 | $43 |
| Lamotrigine | 23 | $599 | $26 |
| Hydrocodone-Acetaminophen | 22 | $530 | $24 |
| Famotidine | 44 | $440 | $10 |
| Lithium Carbonate | 28 | $382 | $14 |
| Ezetimibe | 14 | $375 | $27 |
| Metformin | 35 | $361 | $10 |
| Mupirocin | 11 | $348 | $32 |
| Fluoxetine | 25 | $347 | $14 |
| Sertraline | 21 | $346 | $16 |
| Ssd | 14 | $306 | $22 |
| Lisinopril | 41 | $305 | $7 |
| Clopidogrel | 14 | $290 | $21 |
| Donepezil | 29 | $286 | $10 |
| Timolol Maleate | 18 | $281 | $16 |
| Amiodarone | 12 | $262 | $22 |
| Chlorhexidine Gluconate | 23 | $257 | $11 |
| Brimonidine | 15 | $249 | $17 |
| Triamcinolone Acetonide | 18 | $234 | $13 |
| Losartan | 19 | $227 | $12 |
| Fluticasone Propionate | 11 | $221 | $20 |
| Furosemide | 26 | $221 | $8 |
| Lorazepam | 15 | $209 | $14 |
| Montelukast | 11 | $200 | $18 |
| Metformin Hcl Er | 13 | $197 | $15 |
| Amoxicillin-Clavulanate Potass | 11 | $156 | $14 |
| Glipizide | 19 | $139 | $7 |
| Clindamycin | 13 | $122 | $9 |
| Trazodone | 13 | $119 | $9 |
| Amlodipine Besylate | 17 | $74 | $4 |
| Metoprolol | 14 | $66 | $5 |
2021: 67 drugs
| Eliquis | 90 | $25,624 | $285 |
| Vimpat | 34 | $25,595 | $753 |
| Lantus | 62 | $19,447 | $314 |
| Spiriva | 23 | $11,763 | $511 |
| Incruse Ellipta | 47 | $8,602 | $183 |
| Budesonide | 24 | $7,104 | $296 |
| Divalproex | 31 | $5,837 | $188 |
| Novolin R | 34 | $5,166 | $152 |
| Alendronate | 78 | $4,320 | $55 |
| Xarelto | 12 | $3,838 | $320 |
| Humulin R | 47 | $3,675 | $78 |
| Aripiprazole | 33 | $3,408 | $103 |
| Humalog | 11 | $3,209 | $292 |
| Januvia | 12 | $3,036 | $253 |
| Atorvastatin | 134 | $2,835 | $21 |
| Flovent Hfa | 13 | $2,826 | $217 |
| Levetiracetam | 42 | $2,723 | $65 |
| Nystop | 58 | $2,701 | $47 |
| Levemir Flextouch | 25 | $2,571 | $103 |
| Levothyroxine | 139 | $2,333 | $17 |
| Betamethasone Diprop Augmented | 11 | $2,290 | $208 |
| Duloxetine | 13 | $1,908 | $147 |
| Valproic Acid | 37 | $1,783 | $48 |
| Potassium Chloride | 18 | $1,701 | $94 |
| Basaglar Kwikpen U-100 | 19 | $1,397 | $74 |
| Memantine Hcl Er | 11 | $1,214 | $110 |
| Triamcinolone Acetonide | 107 | $1,212 | $11 |
| Ipratropium-Albuterol | 45 | $1,155 | $26 |
| Ketoconazole | 17 | $1,098 | $65 |
| Olanzapine Odt | 22 | $996 | $45 |
| Pantoprazole | 21 | $983 | $47 |
| Escitalopram | 28 | $961 | $34 |
| Mupirocin | 19 | $791 | $42 |
| Latanoprost | 24 | $782 | $33 |
| Hydrocodone-Acetaminophen | 36 | $733 | $20 |
| Dorzolamide | 11 | $583 | $53 |
| Clotrimazole | 21 | $556 | $26 |
| Tamsulosin | 19 | $502 | $26 |
| Fludrocortisone Acetate | 14 | $489 | $35 |
| Famotidine | 34 | $410 | $12 |
| Olanzapine | 16 | $394 | $25 |
| Cephalexin | 11 | $394 | $36 |
| Lithium Carbonate | 42 | $367 | $9 |
| Phenytoin | 12 | $358 | $30 |
| Furosemide | 42 | $305 | $7 |
| Fluticasone Propionate | 17 | $296 | $17 |
| Losartan | 30 | $293 | $10 |
| Montelukast | 16 | $289 | $18 |
| Gabapentin | 22 | $289 | $13 |
| Oxcarbazepine | 11 | $252 | $23 |
| Ssd | 11 | $244 | $22 |
| Fluoxetine | 26 | $242 | $9 |
| Sertraline | 19 | $220 | $12 |
| Clopidogrel | 18 | $206 | $11 |
| Chlorhexidine Gluconate | 19 | $198 | $10 |
| Spironolactone | 21 | $182 | $9 |
| Metformin Hcl Er | 13 | $165 | $13 |
| Lisinopril | 19 | $150 | $8 |
| Metoprolol | 17 | $150 | $9 |
| Clindamycin | 12 | $127 | $11 |
| Levofloxacin | 12 | $110 | $9 |
| Glipizide | 14 | $108 | $8 |
| Metformin | 15 | $103 | $7 |
| Lorazepam | 12 | $86 | $7 |
| Oxybutynin Chloride Er | 11 | $81 | $7 |
| Donepezil | 14 | $78 | $6 |
| Hydrochlorothiazide | 17 | $76 | $4 |
2020: 57 drugs
| Eliquis | 99 | $23,889 | $241 |
| Lantus | 44 | $13,486 | $306 |
| Latuda | 20 | $12,639 | $632 |
| Vimpat | 27 | $10,928 | $405 |
| Divalproex | 65 | $10,352 | $159 |
| Incruse Ellipta | 42 | $6,640 | $158 |
| Spiriva | 12 | $5,910 | $493 |
| Trulicity | 25 | $5,445 | $218 |
| Procrit | 18 | $5,251 | $292 |
| Levemir | 15 | $5,044 | $336 |
| Alendronate | 115 | $4,572 | $40 |
| Valproic Acid | 60 | $3,977 | $66 |
| Aripiprazole | 37 | $3,964 | $107 |
| Olanzapine | 47 | $3,713 | $79 |
| Humulin R | 46 | $3,348 | $73 |
| Potassium Chloride | 20 | $3,155 | $158 |
| Novolin R | 16 | $2,703 | $169 |
| Flovent Hfa | 11 | $2,323 | $211 |
| Levothyroxine | 109 | $1,850 | $17 |
| Carafate | 11 | $1,821 | $166 |
| Sucralfate | 15 | $1,775 | $118 |
| Sps | 21 | $1,679 | $80 |
| Levetiracetam | 45 | $1,464 | $33 |
| Duloxetine | 12 | $1,383 | $115 |
| Lactulose | 54 | $1,330 | $25 |
| Nystop | 33 | $1,078 | $33 |
| Ipratropium-Albuterol | 45 | $1,056 | $23 |
| Atorvastatin | 72 | $1,039 | $14 |
| Oxcarbazepine | 19 | $1,035 | $54 |
| Pantoprazole | 29 | $891 | $31 |
| Mupirocin | 19 | $863 | $45 |
| Hydrocodone-Acetaminophen | 42 | $853 | $20 |
| Quetiapine | 28 | $756 | $27 |
| Metoclopramide | 13 | $752 | $58 |
| Amantadine | 12 | $688 | $57 |
| Tamsulosin | 34 | $579 | $17 |
| Gabapentin | 11 | $546 | $50 |
| Metformin | 48 | $515 | $11 |
| Latanoprost | 24 | $434 | $18 |
| Omeprazole | 35 | $401 | $11 |
| Lithium Carbonate | 42 | $390 | $9 |
| Triamcinolone Acetonide | 27 | $375 | $14 |
| Digoxin | 11 | $368 | $33 |
| Nystatin | 11 | $315 | $29 |
| Risperidone | 13 | $269 | $21 |
| Finasteride | 14 | $260 | $19 |
| Fluoxetine | 25 | $205 | $8 |
| Metoprolol | 27 | $188 | $7 |
| Mirtazapine | 12 | $187 | $16 |
| Montelukast | 11 | $171 | $16 |
| Clopidogrel | 14 | $168 | $12 |
| Sertraline | 14 | $162 | $12 |
| Losartan | 16 | $152 | $9 |
| Propranolol | 11 | $141 | $13 |
| Furosemide | 19 | $100 | $5 |
| Famotidine | 15 | $99 | $7 |
| Donepezil | 16 | $88 | $6 |
2019: 37 drugs
| Latuda | 27 | $16,462 | $610 |
| Lantus | 29 | $8,971 | $309 |
| Levemir | 23 | $7,725 | $336 |
| Eliquis | 26 | $5,147 | $198 |
| Valproic Acid | 40 | $3,878 | $97 |
| Olanzapine | 57 | $3,287 | $58 |
| Aripiprazole | 14 | $2,987 | $213 |
| Humalog | 11 | $2,496 | $227 |
| Humulin R | 26 | $2,239 | $86 |
| Divalproex Sodium Er | 21 | $1,862 | $89 |
| Tolterodine Tartrate Er | 13 | $1,682 | $129 |
| Nystatin-Triamcinolone | 15 | $1,614 | $108 |
| Alendronate | 40 | $1,536 | $38 |
| Duloxetine | 11 | $1,327 | $121 |
| Nystop | 30 | $1,194 | $40 |
| Divalproex | 27 | $1,193 | $44 |
| Lactulose | 51 | $1,138 | $22 |
| Levothyroxine | 57 | $1,131 | $20 |
| Levemir Flextouch | 11 | $1,131 | $103 |
| Levetiracetam | 16 | $1,024 | $64 |
| Atorvastatin | 47 | $811 | $17 |
| Pantoprazole | 27 | $631 | $23 |
| Tamsulosin | 16 | $452 | $28 |
| Hydrocodone-Acetaminophen | 24 | $371 | $15 |
| Oxcarbazepine | 12 | $302 | $25 |
| Fluticasone Propionate | 13 | $284 | $22 |
| Furosemide | 40 | $247 | $6 |
| Losartan | 32 | $224 | $7 |
| Escitalopram | 14 | $157 | $11 |
| Donepezil | 14 | $150 | $11 |
| Metoprolol | 22 | $141 | $6 |
| Hydrochlorothiazide | 22 | $133 | $6 |
| Famotidine | 14 | $131 | $9 |
| Amlodipine Besylate | 22 | $119 | $5 |
| Sertraline | 13 | $116 | $9 |
| Tramadol | 11 | $104 | $9 |
| Carvedilol | 12 | $86 | $7 |
2018: 22 drugs
| Vimpat | 20 | $11,947 | $597 |
| Latuda | 11 | $6,720 | $611 |
| Breo Ellipta | 11 | $3,383 | $308 |
| Olanzapine | 22 | $2,791 | $127 |
| Valproic Acid | 27 | $2,520 | $93 |
| Oxycodone | 19 | $2,298 | $121 |
| Nystop | 16 | $593 | $37 |
| Atorvastatin | 36 | $582 | $16 |
| Potassium Chloride | 11 | $550 | $50 |
| Levothyroxine | 39 | $531 | $14 |
| Hydrocodone-Acetaminophen | 30 | $484 | $16 |
| Furosemide | 61 | $376 | $6 |
| Clotrimazole | 12 | $369 | $31 |
| Gabapentin | 22 | $357 | $16 |
| Pantoprazole | 13 | $329 | $25 |
| Oxcarbazepine | 12 | $263 | $22 |
| Lactulose | 15 | $236 | $16 |
| Tramadol | 26 | $212 | $8 |
| Losartan | 20 | $149 | $7 |
| Spironolactone | 15 | $114 | $8 |
| Escitalopram | 11 | $110 | $10 |
| Famotidine | 12 | $81 | $7 |
2017: 1 drug
| Warfarin | 12 | $42 | $4 |
Money from drug and device companies
$84 in 2025
| 2025 | 1 | 1 | None | $84 |
| 2024 | 1 | 1 | None | $143 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Teva Pharmaceuticals USA | Austedo Xr | $84 | 1 payment
|
See the published payment
| Teva Pharmaceuticals USA | Meals · 2025-09-30 | Austedo Xr | $84 |
See earlier years (2024)
2024: $143
| Neurocrine Biosciences | Ingrezza | $143 | 1 payment
|
Professional record
- NPI
- 1811410145
- Licence
- CA 95006643
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- 5748 San Lorenzo Dr, San Jose, CA, 95123
- NPI first listed
- 2017-07-19
- NPI last updated
- 2017-07-19
This is when the NPI record was last certified, not a medical board exam.